Cancer Drug Destroys Tumors in Pre-Clinical Trials
October 10, 2014
(Medical Xpress) – Scientists at QIMR Berghofer Medical Research Institute have used an experimental drug produced from the seeds of a rainforest plant to cure solid cancer tumours in pre-clinical trials. The study led by Dr Glen Boyle at QIMR Berghofer’s Cancer Drug Mechanisms group found a single injection of the drug EBC-46 led to rapid breakdown of tumours in a range of human tumour models. Dr Boyle says the findings of the pre-clinical trials at QIMR Berghofer suggest the drug could be effective in human patients.